Douglas Warner
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Douglas Warner is currently Chief Medical Officer at Tyra Biosciences, Inc. since 2024.
Formerly, Dr. Warner was Chief Medical Officer at eFFECTOR Therapeutics, Inc. from 2022 to 2024 and Executive Medical Director at Amgen, Inc. Education includes an undergraduate degree from the University of Pennsylvania, an MBA from UCLA Anderson School of Management, and a doctorate from Duke University School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC -.--% | 2026-05-04 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2024-09-09 |
| Companies | Position | End |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-06-20 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions